Pharmacokinetics of eribulin mesylate in patients with solid tumors receiving repeated oral rifampicin.

Translated title of the contribution: Pharmacokinetics of eribulin mesylate in patients with solid tumors receiving repeated oral rifampicin.
  • L.A. Devriese
  • , P.O. Witteveen
  • , J. Wanders
  • , K. Law
  • , G. Edwards
  • , L. Reyderman
  • , W Copalu
  • , F. Peng
  • , S. Marchetti
  • , J.H. Beijnen
  • , AD Huitema
  • , E.E. Voest
  • , J.H.M. Schellens

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Pharmacokinetics of eribulin mesylate in patients with solid tumors receiving repeated oral rifampicin.'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science